Trial design, Consultancy for the realization of clinical projects, Project management, Regulatory affairs (application and reports to authorities),Quality management,Monitoring,CTMS EasyClin® Data management, Medical writing,Metrics development,Bio-statistical analysis,Pharmacovigilance,Complete drug support
Prospects for clinical research industry in India
After more than a decade’s experience in participating in global clinical research, India has firmly established itself as an emerging destination for global biopharmaceutical companies. India’s success story has been aided by uniquely differentiating factors which are well documented including a huge and growing disease burden, diseases unique to the region, medical expertise, transforming healthcare market manifested by growing infrastructure and technology, significant and diverse population, talented resources and an enabling regulatory environment that has swiftly adapted itself to global standards. The last decade saw these advantages being gradually translated from a foreseen business potential into reality.
Recently, there have been mixed developments influenced by an evolving regulatory and legal framework, and adverse media reports, that have placed India’s clinical research in the limelight. Product patent requirements that India has signed as a part of the TRIPS agreement make it imperative for India to innovate and introduce products that are relevant to the country. The disease profile and burden of our population is also transforming from communicable diseases, rampant in the past, to lifestyle disorders in addition to certain neglected diseases. Hence, in many ways, we are now globalized even from a health stand point, which necessitates us to innovate and propagate clinical research to help alleviate the unmet health needs of India.
On the regulatory front, there have been developments which have evoked a lot of response from industry stakeholders. The issue of compensation, which has been a grey area for long, is now receiving much desired attention. The initiative by the Ministry of Health to engage various stake-holders in discussions on the draft compensation guidelines is a welcome move. The industry, academia and all relevant stakeholders agree and believe in-principle to compensate clinical research participants. A comprehensive framework on compensation will help plug the hole on a highly contentious issue.
The appointment and constitution of New Drug Appraisal committees (NDAC) to assist in reviewing clinical research proposals across therapeutic areas is a good initiative in strengthening the technical review process by regulatory authorities and has been well received by the industry. The time to review and comment is expected to normalize once the process becomes well oiled.
The recent media reporting and activism against clinical research has significantly impacted the decision making and future plans of various stakeholders in the clinical research industry. The intentions in most cases may be noble, but misconceptions and misreporting have triggered knee-jerk reactions that have led to unpredictability in decision making. Despite the clinical research journey in India being about 15 years, the industry has evolved significantly and has a fairly robust framework in place for the conduct of clinical trials.
If anything, the recent turn of events have led to fortifying the fundamentals of conducting clinical research in India with the industry stepping up the ante on compliance, quality and zero tolerance towards unethical practices at sites and often going beyond their roles and responsibilities in doing so. Many of the sites have put in additional resources, procedures and processes to ensure that there is consistency and scalability in doing multiple projects. The depth of scrutiny and review of proposals by regulatory authorities is instilling more confidence amongst stakeholders, including sponsors and patients.
Given the existing strong fundamentals in India and lessons learnt, it is reasonable to say that some of the current setbacks are temporary and that the clinical research paradigm will equilibrate to a better and balanced one in the near term future.
The global biopharmaceutical industry is at an inflection point with rising costs and dwindling research pipelines. This is further compounded by the 2015 patent cliff when a significant number of molecules go off-patent. One of the big emerging opportunities for India is in the biosimilars space. Indian biopharma companies are already partnering with global CROs, thereby reversing trends in global clinical development.
The US FDA’s recent endorsement of risk-based approach to monitoring vide the draft monitoring guidance is expected to change the monitoring paradigm in the future. The single approach that was applied uniformly across all geographies and sites irrespective of the risk criteria could cease and be replaced with a smarter methodology of applying increasing or decreasing monitoring efforts depending on a variety of risk factors like geographies, type of sites, maturity of sites, compliance levels, previous track records and so on.
Technology will be increasingly used as a driving force to develop services and solutions and we are already seeing this at Quintiles through Quintiles Infosario®, a comprehensive, fully integrated suite of data-driven services that enables optimized drug development. Given the technical expertise and skilled manpower available in India, we have the advantage in being an early adopter and driver in these technology-enabled services and to be able to service global needs in this domain.
India’s advantage in business processes has already been leveraged in preclinical services like data management and pharmacovigilance. This is expected to grow at a healthy rate in future as well. New models of engagement and outsourcing will emerge to create a more efficient and effective delivery system.
Efforts to enhance communication to sites and patients as well as simplifying management of clinical studies at the hospitals has opened up new avenues for technology solution development, which requires a combination of experience in clinical research as well as software solution development.
Central laboratory and related analysis for standardized safety testing is another area that will evolve with the growth of clinical trials in India. The current offering by central labs will have to move upstream in being able to perform sophisticated analysis of unconventional biomarkers. India in the past has always prided itself on replicating complex wet lab analysis. In the clinical research arena, complex tests that have been retained in western geographies could be expected to move East to countries like India and China.
Every difficult situation can be viewed as a problem or an opportunity. In the current environment of increased regulatory, legal and media related challenges, there will be avenues where entrepreneurs will convert challenges into opportunities.
It will be fair to say that though there are temporary challenges in clinical research, the outlook in the medium to long term is bright given the strong fundamentals in this domain. When this happens it will open up opportunities on multiple fronts which will not be on the same template witnessed in early 2000.India has every opportunity to rise stronger and become a region of excellence in multiple areas.
Our core competences are:
- Trial design
- Consultancy for the realization of clinical projects
- Project management
- Regulatory affairs (application and reports to authorities)
- Quality management
- CTMS EasyClin®
Based on reliable co-operations with long-term international partners, we also implement:
- Data management
- Medical writing
- Metrics development
- Bio-statistical analysis
- Complete drug support
Clients use our services for successful completion of complex clinical trials.
The eClinical solution EasyClin® allows our customers and us to keep an up-to-date overview of all trial processes. Our project management services include:
• Study set-up, support with contract negotiations, investigator recruitment like site identification, selection and if required feasibility
• Design of study documents (study protocol, CRF, contracts etc.)
• Trial Master File set-up and maintenance
• Overall planning and organization
• Review of reports
• Collaborations (Biometry, Medical Writing, Pharmacovigilance, Statistical Analysis, Drug Supply)
Benefit from our clinical monitors. They are well trained scientists, mostly multilingual and experienced in different indications. We offer this service in various countries. Our monitoring services include:
• Start-up and initiation tasks (Assessment- and Initiation Visits)
• Investigator Site File set-up and maintenance
• SDV (Source Data Verification)
• Reporting (comprehensive and timely visit reports)
• Collection and maintenance of essential documents
• Site management
• Query resolution
• Drug accountability
Take advantage of our quality management which is part of permanent review by internal and external specialists. In addition to our quality assurance procedures we provide the following services:
• SOP Management
• CRO Evaluation
Our experienced team will be glad to support you through all regulatory affairs. This applies to national and local authorities as well as ethic authorities and all related tasks . We have passed regular Sponsor audits successfully.
List of Clinical Research Org./Regulatory/Clinical Trials & other Technical Services
Samhita Consultants is consulting organization engaged in to provide consultations and services for pharmaceutical and cosmetic industries.... Designing of Plant
CATALYST PHARMA CONSULTING
Consultants providing a wide range of consulting services to Pharmaceutical, Biotechnology and Active Pharmaceutical Ingredients (APIs) Industry.... Validation
Afra Pharma Consultant
We are a leading pharma consult center based in Pune, India. We cater all the activities related to Pharma companies. We specialize in regulatory support and can cater to all pharmaceutical needs. We are a one stop solution for Pharmaceuticals. Our S... Regulatory Services
KPS Clinical Services Pvt. Ltd.
KPS Clinical Services Pvt. Ltd. as a Greater Noida based Contract Research Organization (CRO). Our firm focuses on providing various services e.g. Clinical trial & BA/BE Study execution & management, Data collection and management & Reporting / manuscrip... PDCTM
METINA CONSULTANTS offers end to end regulatory services starting from regulatory strategy, submission till product approval for emerging markets i.e. Russia, Ukraine, Brazil, Mexico, Venezuela, ASEAN, MENA, GCC, and South Africa. Our business associates ... Emerging Markets Regulatory Services
Cyclone will assist your organization in Preparation, Compilation and registration of Dossiers in Different Countries of the world. Dossiers for : Singapore, Malaysia, Indonesia, Philippines, Thailand, Vietnam, Brunei, Myanmar, Cambodia, CIS Countries, Ru... DMFs
Syngene International Ltd
Syngene is offering services in chemistry, biology, analytical, toxicology, DMPK, preclinical & formulation development. From early stage discovery and process development through to cGMP manufacturing, we provide customized services to academia, pharmace... Custom Synthesis
Zodiac Pharmaceutical Services
Zodiac Pharma is a regulatory affairs (dossier) consulting firm. We offer a wide range of services in the areas of in the areas of regulatory affairs and pharmaceutical product development for small to medium size pharmaceutical companies... Product Registration
DOCENT PHARMA SERVICES
DocentPharma offers the following eCTD services to ensure regulatory acceptable eCTD enabled submissions: •Preparation & Assist for Dossier assembly and compilation in eCTD Format (Module 1 – Regional, CTD Module 2 to Module 5) •Review & Validate eCTD D... eCTD DOSSIER
Perfect Pharmaceutical Consultants Pvt Ltd
Perfect Pharmaceutical Consultants Pvt Ltd (PPC) is highly knowledged and 20 years experienced well established Regulatory Affairs Consulting company.PPC specializes in CTD Dossiers US European Drug Master Files for API Intermediates, Drug Products, Excip... US DMF
Labtop Instruments Pvt Ltd.
Manufacturers of Laboratory Instrument, Stability Test Chamber, Cooling Incubator, Bacteriological Incubator, Laboratory Incubator, Cryo Bath, Blood Bank Equipment like Platelet Incubator, Blood Bag Tube Sealer, Blood Collection Monitor, Blood Bank Refrig... Stability Test Chamber
Optimus Pharma Consulting
OPTIMUS Pharma Consulting is a Business Advisory and Service Provider to the Drug and Medical Devices industry. We are a service provider in the areas of REGULATORY; BIOMETRICS; CLINICAL RESEARCH; INDEPENDENT AUDITING; DRUG & DEVICE DEVELOPMENT CONSULTING... Biometrics
Microtherapeutic Research Labs Pvt. Ltd.
MTR is one of the leading CRO in India, audited and accredited by DCGI,NABL,USFDA,ANVISA,AFSAAPs. We conduct BA/BE studies, pre-clinical and clinical trial, Bio-analytical and analytical services for the pharma industries ti enhance R&D success.... Pre Clinical
Skymax Research & Regulations
Skymax, a truly research base organization believes in constant development of excellence in the field of research and development as per the need of the Pharma industries. We are into contract Research & Development and Regulations management to cater ... Regulatory services provider
AXIS Clinicals Limited
AXIS Clinicals Ltd is Clinical Research Organization committed to serving the global pharmaceutical and biotech industry with the global standards and most accurate results ranging from BioEquivalence and phase 2 to 4 clinical trials. In compliance with I... Clinical Pharmacology
Suven Life Sciences Ltd.
Suven is a contract research and custom manufacturing organization having US FDA approved and WHO GMP certified facilities for manufacture of intermediates and APIs.... Bulk Drugs
LOTUS CLINICAL RESEARCH ACADEMY
1. Conduct of Phase II, III & IV /PMS / Investigator Initiated Trials 2. Oracle based Data Mng., SAS based Statistical and CSR writing services 3. Monitoring services - Clinical Trials & BA/BE Studies 4. CRO & BA/BE Post Audit Services 5. Medical Writ... Auditing Servcies
Surmount Clinical Research Services
Surmount Clinical Research Services is a Site Management Organization (SMO) which acts as a common platform between the Principal Investigator(s) and study Sponsor(s)/CRO(s) for the successful execution of clinical trials. We provide excellent clinical... Clinical Research Services
Sristek is committed to be the CRO of first choice in the area of contract research services by combining extreme focus on quality and compliance to regulations & guidelines with operational excellence and continually improve the effectiveness of the Qual... Clinical Data Management
Sanmour Pharma Pvt. Ltd
Full fledged pharma contract R & D company with its own full fledged research and process development facility. Thus is now fully geared up to provide top class value and services to pharma majors globally.... Contract Formulation
Agaram Instruments (P) Ltd.
Agaram specializes in providing Laboratory Information Management Systems, Instrument-Interfacing solutions offers development services for laboratory automation projects and laboratory instrumentation manufacturers around the world.... Digital Polarimeter
SGS Life Science Services R&D/QC
SGS Life Science Services is the leading contract service organization providing GMP/GLP testing services to pharma, biopharma, medical device,and healthcare-related companies.... Pharma Laboratory
TRUST CHEM SOLUTION
Our Quality Advisors and associates understand the inner working of Quality, Regulastory as well as pragmatic concerns involved in manufacturing products, validating Processes, laboratory practices, Vendors, Qualifying the Equipments and Instruments and p... Quality Management Systems